mProX™ Human ACVR1 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Kinase Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Lena
Verified Customer
Bob
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 Acvr1G328V Hyperactivates BMP Signaling and Stimulates Glial Cell Proliferation
Adenoviruses expressing GFP (Ad-GFP) or GFP plus Cre (Ad-GFP-Cre) were used to transduce cells. Ad-GFP-Cre induced recombination of the conditional allele and phosphorylated SMAD1, the canonical BMP signaling effector, in Acvr1floxG328V/+ cells, but not SMAD2.
Ref: Fortin, Jerome, et al. "Mutant ACVR1 arrests glial cell differentiation to drive tumorigenesis in pediatric gliomas." Cancer Cell 37.3 (2020): 308-323.
Pubmed: 32142668
DOI: 10.1016/j.ccell.2020.02.002
Research Highlights
These findings gave rise to a potential new therapeutic approach for FOP and reveal a novel mechanism of extraskeletal bone production in the disease.
Hino, Kyosuke, et al. "Neofunction of ACVR1 in fibrodysplasia ossificans progressiva." Proceedings of the National Academy of Sciences 112.50 (2015): 15438-15443.
Pubmed:
26621707
DOI:
10.1073/pnas.1510540112
These findings reveal a new characteristic of FOP-mutant ACVR1 and suggest that anti-ACVR1 antibodies are not a suitable treatment option for FOP.
Aykul, Senem, et al. "Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1." The Journal of Clinical Investigation 132.12 (2022).
Pubmed:
35511419
DOI:
10.1172/JCI153792